CINRYZE Rx

Select the drug indication to add to your list

CINRYZE

Hereditary angioedema
Only 4 drugs may be compared at once

Generic Name and Formulations:

C1 inhibitor (human) 500 Units/vial; lyophilized pwd for IV infusion after reconstitution; preservative-free.

Company:

Shire US, Inc.

Select therapeutic use:

Indications for CINRYZE:

Routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).

Adult:

Give by IV infusion at a rate of 1mL/min (10mins). 1000 Units every 3–4 days.

Children:

Not recommended.

Warnings/Precautions:

Contains human plasma; monitor for possible infection transmission. Have epinephrine available to treat hypersensitivity reactions. Monitor patients with known risk factors for thrombotic events. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

C1 inhibitor.

Adverse Reactions:

Upper respiratory tract infection, sinusitis, rash, headache; thrombotic events, hypersensitivity reactions (may be severe); discontinue if occurs.

Note:

To report infections that may have been transmitted by Cinryze, call CinryzeSolutions at (877) 945-1000.

Generic Availability:

NO

How Supplied:

Single-use vial—1

CINRYZE 500 units vials (Qty:20)

appx. price $58269.00